Stocksigma LogoStocksigma Logo

KIMS Approves Q2 Results, Key Reappointments, and Subsidiary Merger

Krishna Institute of Medical Sciences (KIMS) approved unaudited financial results for the quarter ended 30th Sep'26, posting consolidated revenue from

KIMS Approves Q2 Results, Key Reappointments, and Subsidiary Merger

Krishna Institute of Medical Sciences Ltd 路 Outcome 路 05 Nov 2026, 12:17 am

KIMS Approves Q2 Results, Key Reappointments, and Subsidiary Merger Krishna Institute of Medical Sciences (KIMS) approved unaudited financial results for the quarter ended 30th Sep'26, posting consolidated revenue from operations of Rs. 13,444 million and net profit of Rs. 746 million. The board cleared the merger of wholly-owned subsidiary KIMS Hospitals Pvt Ltd into the parent company. Additionally, KIMS Swastha entered an O&M agreement for Westfort Hospital, Thrissur. Dr. Bhaskara Rao Bollineni (CMD) and Dr. Abhinay Bollineni (Director & CEO) were reappointed for five-year terms. KIMS also acquired a 51% stake in Sarvottam Health Care for Rs. 795 million.

Original exchange filing (PDF)

More announcements from Krishna Institute of Medical Sciences Ltd

All Krishna Institute of Medical Sciences Ltd announcements